Aladdin Ali Deeb

Dr. Aladdin Ali Deeb

Jena University Hospital, Jena, Thuringia, Germany
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2022 in Annals of Surgery
Verified
Journal Article
Closed access
USUtz Settmacher
Utz Settmacher
ADAladdin Ali Deeb
Aladdin Ali Deeb
LCLaurent Coubeau
Laurent Coubeau
UCUmberto Cillo
Umberto Cillo
PLPål-Dag Line
Pål-Dag Line
FRFalk Rauchfuß
Falk Rauchfuß
Objective: To present technical details and short-term experiences of liver transplantation as a 2-stage procedure using small for size grafts in a multicenter cohort study. Background: Two-stage liver transplantation using small for size grafts should be a feasible procedure with lower morbidity and mortality rates. Retrospective cohort study between 2015 and 2022 with multicenter experience. Twenty-three resection and partial liver transplantation with delayed total hepatectomy procedures for noncirrhotic indications were performed in 6 European centers (20 with grafts from living donors and 3 after deceased donation). Procedure’s feasibility, graft volumetric changes, morbidity, and mortality of donor and recipient were explored. Results: There was a low donor morbidity (4.3%) in our cohort. Hypertrophy of the graft was rapid (mean graft volume increases 107% between both stages) and offered the opportunity for remnant hepatectomy after a median of 14 days. In all cases, portomesenteric flow was routed to the graft by right remnant portal vein ligation. Portal vein inflow modulation to alleviate transient harmful portal hypertension was not needed in any case. Early postoperative mortality (4.3%) of the recipients were low. Ten patients suffered from complications ≥IIIb according to the Clavien-Dindo classification. Conclusions: Two-stage liver transplantation is a feasible option for noncirrhotic patients allowing the safe use of small for size grafts and could possibly be extended with caution to liver diseases with portal hypertension and cirrhosis. The resection and partial liver transplantation with delayed total hepatectomy technique might be a viable option for expanding the donor pool given the current organ shortage especially for low–model of end stage liver disease patients.

13 March 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
FRFalk Rauchfuss
Falk Rauchfuss
ADAladdin Ali Deeb
Aladdin Ali Deeb
OROliver Rohland
Oliver Rohland
FDFelix Dondorf
Felix Dondorf
MAMichael Ardelt
Michael Ardelt
USUtz Settmacher
Utz Settmacher
Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration. However, recent studies showed that well-selected patients after a neo-adjuvant treatment benefit from liver transplantation with good long-term outcomes. The role of living donor liver transplantation is unclear for this indication. The current study focuses on LDLT for intrahepatic cholangiocarcinoma.

1 June 2023 in HepatoBiliary Surgery and Nutrition
Verified
Journal Article
Open access
PDF file
ADAladdin Ali Deeb
Aladdin Ali Deeb
USUtz Settmacher
Utz Settmacher
MAMichael Ardelt
Michael Ardelt
FDFelix Dondorf
Felix Dondorf
OROliver Rohland
Oliver Rohland
FRFalk Rauchfuß
Falk Rauchfuß
Original Article Adipose tissue induces a better liver regeneration after living liver donation in normal weight donors Aladdin Ali Deeb, Utz Settmacher, Michael Ardelt, Felix Dondorf, Oliver Rohland, Falk Rauchfuß

13 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
LSLaura Schwenk
Laura Schwenk
OROliver Rohland
Oliver Rohland
ADAladdin Ali Deeb
Aladdin Ali Deeb
FDFelix Dondorf
Felix Dondorf
USUtz Settmacher
Utz Settmacher
FRFalk Rauchfuss
Falk Rauchfuss
Background: Data about liver transplantation for mixed tumors from hepatocellular carcinoma to cholangiocarcinoma are limited. Furthermore, the diagnosis of intrahepatic cholangiocarcinoma or combined tumors in a cirrhotic liver is considered a contraindication for transplantation. Our aim was to evaluate the long-term outcomes of patients with incidental cholangiocarcinoma or combined tumors after liver transplantation. Methods: In our descriptive analysis, data were evaluated from all patients since 2010 who received a liver transplant due to an assumed hepatocellular carcinoma at Jena University Hospital. Survival rates were determined using the Kaplan–Meier method. Results: Between January 2010 and December 2022, an incidental intrahepatic cholangiocarcinoma was found in eight patients post-transplant. Four combined hepatocellular and cholangiocarcinoma and four sole intrahepatic cholangiocarcinomas were found. A recurrence through distant metastases from combined hepatocellular- and cholangiocarcinoma was found in one patient at one year after transplantation. Another patient developed a pulmonary primary tumor independently one year post-transplant. The recurrence rate was at 14.3%. While two patients died, the 1- and 5-year overall survival rates post-transplant were 87.5% and 75%, respectively. Conclusion: Patients with intrahepatic cholangiocarcinoma or combined hepatocellular- and cholangiocarcinoma could profit from liver transplantation.

7 August 2023 in Liver Transplantation
Verified
Journal Article
Closed access
ADAladdin Ali Deeb
Aladdin Ali Deeb
USUtz Settmacher
Utz Settmacher
JFJohannes Fritsch
Johannes Fritsch
FDFelix Dondorf
Felix Dondorf
OROliver Rohland
Oliver Rohland
FRFalk Rauchfuss
Falk Rauchfuss
Sarcopenic obesity impairs the outcome after liver transplantation. The effect of this on liver regeneration has not yet been studied. The aim of this study was to evaluate the potential effect of body composition changes on liver volume gain after living donor liver transplantation. We observed liver regeneration in 100 patients who underwent living donor liver transplantation using right lobe grafts (Segments V-VIII). Liver volumetry and body composition analysis were performed based on CT images with special software. The gain of liver volume was calculated between 2 points in time considering the absolute and percentage values: before surgery and early after surgery, with a median time of 10 days. Pearson’s correlation and multivariate analysis using stepwise multiple regression were used to examine the potential correlation between body composition and liver volume gain. The liver volume increase was significantly negatively correlated with adipose tissue in the body stem (r = −0.4, p < 0.001) and positively correlated with psoas mass (r = 0.24, p = 0.02). These results correspond with those of the multiple regression analysis, which indicated adipose tissue (ß = −1.0, p < 0.001) and psoas mass (ß = 0.12, p < 0.001). The presence of malignancy as an indication for liver transplantation was another significant independent factor negatively affecting liver growth (ß = −13.1, p = 0.046). Sarcopenic obesity predicts an impaired liver volume increase after living donation. This could worsen the postoperative outcome. The role of alimentary interventions and exercises in improving body composition and thus postoperative outcome should be evaluated through prospective interventional studies.

17 November 2022 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
ADAladdin Ali Deeb
Aladdin Ali Deeb
FRFalk Rauchfuß
Falk Rauchfuß
NGNikolaus Gaßler
Nikolaus Gaßler
FDFelix Dondorf
Felix Dondorf
OROliver Rohland
Oliver Rohland
USUtz Settmacher
Utz Settmacher
IntroductionInduction of liver regeneration represents an option to expand the resectability in patients with expected small future liver remnant (FLR). The aim of this cohort-study is to compare the liver regeneration between different surgical procedures, including novel procedures such as two-stage living donor liver transplantation using small-for-size grafts. MethodsForty-three patients with colorectal liver metastases were included between 2004 and 2020. They underwent one of the following three procedures: portal vein embolization (PVE), associated liver partition with portal vein ligation for staged hepatectomy (ALPPS), and living donor two-stage liver transplantation (LT). The volume gain of the future liver remnant was analyzed in comparison between the three mentioned procedures. ResultsThe type of surgery performed had a significant correlation with liver regeneration with a strong effect on the benefit of ALPPS and liver transplantation, respectively (r = .6, p = .00003). The type of surgery was the only independent co-factor in the multiple regression, which showed a significant influence on FLR-increase favoring two-stage transplantation compared to the other two related procedures (ss = .12, T = 3.9, p = .0004). The histological and immunohistochemical studies also showed a clear advantage of proliferation to the benefits of two-stage liver transplantation compared with ALPPS. ConclusionTwo-stage liver transplantation using small-for-size grafts induces better FLR-increase than portal vein embolization or ALPPS in patients with colorectal liver metastases.